Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Reversal of warfarin-induced hemorrhage in the emergency department.

Zareh M, Davis A, Henderson S.

West J Emerg Med. 2011 Nov;12(4):386-92. doi: 10.5811/westjem.2011.3.2051.

2.

Pharmacologic interventions for reversing the effects of oral anticoagulants.

Kalus JS.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.

PMID:
23640528
3.

Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.

Le Roux P, Pollack CV Jr, Milan M, Schaefer A.

J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm. Review.

PMID:
25081496
4.

Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.

Barton CA, Johnson NB, Case J, Warden B, Hughes D, Zimmerman J, Roberti G, McMillian WD, Schreiber M.

Am J Emerg Med. 2015 Nov;33(11):1562-6. doi: 10.1016/j.ajem.2015.06.010. Epub 2015 Jun 12.

PMID:
26143317
5.

Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

World Neurosurg. 2014 Jan;81(1):110-5. doi: 10.1016/j.wneu.2012.12.002. Epub 2012 Dec 5.

PMID:
23220122
6.

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Circulation. 2013 Sep 10;128(11):1234-43. doi: 10.1161/CIRCULATIONAHA.113.002283. Epub 2013 Aug 9.

7.

The clinical use of prothrombin complex concentrate.

Ferreira J, DeLosSantos M.

J Emerg Med. 2013 Jun;44(6):1201-10. doi: 10.1016/j.jemermed.2012.12.022. Epub 2013 Apr 18. Review.

PMID:
23602147
8.

Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.

Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R.

Transfusion. 2009 Jun;49(6):1171-7. doi: 10.1111/j.1537-2995.2008.02080.x. Epub 2009 Feb 6.

PMID:
19210325
9.

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.

Guest JF, Watson HG, Limaye S.

Clin Ther. 2010 Dec;32(14):2478-93. doi: 10.1016/j.clinthera.2011.01.011.

PMID:
21353116
10.

Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.

Bruce D, Nokes TJ.

Crit Care. 2008;12(4):R105. doi: 10.1186/cc6987. Epub 2008 Aug 15.

11.

Warfarin-induced bleeding complications - clinical presentation and therapeutic options.

Wiedermann CJ, Stockner I.

Thromb Res. 2008;122 Suppl 2:S13-8. doi: 10.1016/S0049-3848(08)70004-5. Review.

PMID:
18549907
12.

An update of consensus guidelines for warfarin reversal.

Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH).

Med J Aust. 2013 Mar 4;198(4):198-9.

PMID:
23451962
13.

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.

Tanaka KA, Szlam F, Dickneite G, Levy JH.

Thromb Res. 2008;122(1):117-23. Epub 2007 Oct 31.

PMID:
17977586
14.

Limb-threatening Deep Venous Thrombosis Complicating Warfarin Reversal with Three-factor Prothrombin Complex Concentrate: A Case Report.

Jablow LM, Jones CW, Carroll GG, Wilsey SV, Haroz R.

J Emerg Med. 2016 Jan;50(1):28-31. doi: 10.1016/j.jemermed.2015.02.053. Epub 2015 Oct 24.

PMID:
26603365
15.

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.

Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group.

Med J Aust. 2004 Nov 1;181(9):492-7. Review. Erratum in: Med J Aust. 2005 Jan 3;182(1):48.

PMID:
15516194
16.

Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.

Frumkin K.

Ann Emerg Med. 2013 Dec;62(6):616-626.e8. doi: 10.1016/j.annemergmed.2013.05.026. Epub 2013 Jul 3. Review.

PMID:
23829955
17.

Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.

Perzborn E, Heitmeier S, Laux V, Buchmüller A.

Thromb Res. 2014 Apr;133(4):671-81. doi: 10.1016/j.thromres.2014.01.017. Epub 2014 Jan 21.

18.

Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients.

Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A.

Cochrane Database Syst Rev. 2015 Jul 7;(7):CD010555. doi: 10.1002/14651858.CD010555.pub2. Review.

PMID:
26151108
19.

Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF.

Thromb Haemost. 1997 Mar;77(3):477-80.

PMID:
9065997
20.

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal.

Chapman SA, Irwin ED, Abou-Karam NM, Rupnow NM, Hutson KE, Vespa J, Roach RM.

World J Emerg Surg. 2014 Apr 15;9:27. doi: 10.1186/1749-7922-9-27. eCollection 2014.

Supplemental Content

Support Center